Abstract
Type II (inducible) nitric oxide synthase (NOS) may play an important role in pulmonary pathophysiology, yet it remains controversial whether human tissues are capable of expressing this protein. Therefore, a polyclonal antibody (8196) was raised against type II NOS from induced RAW 264.7 macrophages and used to investigate the expression of this enzyme in human lung tissue. Anti-type II NOS antibody did not cross-react with either neuronal (type I) or endothelial (type III) constitutive NOS, whereas a 130- kDa protein was detected in cytosol from induced macrophages or liver removed from lipopolysaccharide (25 mg/kg)-treated rats. Cells or tissues that lacked NOS activity did not express immunoreactive proteins. Similarly, in grossly normal human lung tissue, no immunoreactivity was detected with the anti- type II NOS antibody. In contrast, strong immunoreactivity was detected in alveolar macrophages present in lung tissue from a patient with bronchiectasis and acute bronchopneumonia. These data demonstrate that human alveolar macrophages are able to express type II NOS and support a role for this enzyme in pulmonary inflammatory pathophysiology.
Original language | English (US) |
---|---|
Pages (from-to) | L722-L727 |
Journal | American Journal of Physiology - Lung Cellular and Molecular Physiology |
Volume | 266 |
Issue number | 6 10-6 |
DOIs | |
State | Published - 1994 |
Externally published | Yes |
Keywords
- adult respiratory distress syndrome
- bronchiectasis
- chronic obstructive pulmonary disease
- cytokine
- inflammation
- liver
- macrophage
- nitric oxide synthase
- pneumonia
- pulmonary
ASJC Scopus subject areas
- Physiology
- Pulmonary and Respiratory Medicine
- Physiology (medical)
- Cell Biology